Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ramón Cacabelos. (2022) What have we learnt from past failures in Alzheimer’s disease drug discovery?. Expert Opinion on Drug Discovery 17:4, pages 309-323.
Read now
Read now
Ramón Cacabelos, Iván Carrera, Olaia Martínez-Iglesias, Natalia Cacabelos & Vinogran Naidoo. (2021) What is the gold standard model for Alzheimer’s disease drug discovery and development?. Expert Opinion on Drug Discovery 16:12, pages 1415-1440.
Read now
Read now
Articles from other publishers (23)
Lucia Zakharova, Gulnara Gaynanova, Elmira Vasilieva, Leysan Vasileva, Rais Pavlov, Ruslan Kashapov, Konstantin Petrov & Oleg Sinyashin. (2023) Recent Nanoscale Carriers for Therapy of Alzheimer's Disease:
Current Strategies and Perspectives. Current Medicinal Chemistry 30:33, pages 3743-3774.
Crossref
Crossref
Olaia Martínez-Iglesias, Vinogran Naidoo, Iván Carrera, Juan Carlos Carril, Natalia Cacabelos & Ramón Cacabelos. (2023) Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders. Biology 12:9, pages 1156.
Crossref
Crossref
Laura Marinela Ailioaie, Constantin Ailioaie & Gerhard Litscher. (2023) Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?. Pharmaceutics 15:3, pages 916.
Crossref
Crossref
Chun-Wang Meng, Hao-Yu Zhao, Huan Zhu, Cheng Peng, Qin-Mei Zhou & Liang Xiong. (2023) Novel Indane Derivatives with Antioxidant Activity from the Roots of Anisodus tanguticus. Molecules 28:3, pages 1493.
Crossref
Crossref
Ramón Cacabelos, Juan C Carril, Lola Corzo, Rocío Pego, Natalia Cacabelos, Margarita Alcaraz, Adriana Muñiz, Olaia Martínez-Iglesias & Vinogran Naidoo. (2023) Pharmacogenetics of anxiety and depression in Alzheimer's disease. Pharmacogenomics 24:1, pages 27-57.
Crossref
Crossref
Priyanka Kumari, Rusham Das & Amit Kumar Goyal. 2023. Nanomedicine-Based Approaches for the Treatment of Dementia. Nanomedicine-Based Approaches for the Treatment of Dementia
235
264
.
F. Trotta, L. Biscetti & A. Cherubini. 2023. Optimizing Pharmacotherapy in Older Patients. Optimizing Pharmacotherapy in Older Patients
269
287
.
Alberto Benussi, Valentina Cantoni, Mario Grassi, Lucie Brechet, Christoph M. Michel, Abhishek Datta, Chris Thomas, Stefano Gazzina, Maria Sofia Cotelli, Marta Bianchi, Enrico Premi, Yasmine Gadola, Maria Cotelli, Marta Pengo, Federica Perrone, Maria Scolaro, Silvana Archetti, Eino Solje, Alessandro Padovani, Alvaro Pascual‐Leone & Barbara Borroni. (2022) Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease. Annals of Neurology 92:2, pages 322-334.
Crossref
Crossref
Florian Klammers, Andreas Goetschi, Aynur Ekiciler, Isabelle Walter, Neil Parrott, Stephen Fowler & Kenichi Umehara. (2022) Estimation of Fraction Metabolized by Cytochrome P450 Enzymes Using Long-Term Cocultured Human Hepatocytes. Drug Metabolism and Disposition 50:5, pages 566-575.
Crossref
Crossref
Ramón Cacabelos. (2022) Pharmacogenetics for Improving Efficacy and Safety in Drug Development
and for Reducing Costs in Alzheimer’s Disease. Current Pharmacogenomics and Personalized Medicine 19:1, pages 3-6.
Crossref
Crossref
Ramon Cacabelos. 2022. Alzheimer's Disease Drug Development. Alzheimer's Disease Drug Development
404
417
.
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, Lola Corzo, Natalia Cacabelos, Rocío Pego & Juan C. Carril. (2022) Personalized Management and Treatment of Alzheimer’s Disease. Life 12:3, pages 460.
Crossref
Crossref
Arezoo Rastegari, Maliheh Safavi, Fahimeh Vafadarnejad, Zahra Najafi, Roshanak Hariri, Syed Nasir Abbas Bukhari, Aida Iraji, Najmeh Edraki, Omidreza Firuzi, Mina Saeedi, Mohammad Mahdavi & Tahmineh Akbarzadeh. (2021) Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer’s disease. Molecular Diversity 26:1, pages 409-428.
Crossref
Crossref
Ping-Song Chou, Ling-Chun Huang, Tzyh-Chyuan Hour, Chen-Wen Yen & Yuan-Han Yang. (2022) Impact of the CYP2D6 single nucleotide polymorphism on the concentration of and therapeutic response to donepezil in mild-to-moderate Alzheimer's disease. Journal of the Formosan Medical Association 121:1, pages 409-415.
Crossref
Crossref
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, Lola Corzo, Natalia Cacabelos, Rocío Pego & Juan C. Carril. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
275
387
.
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, Natalia Cacabelos & Juan C. Carril. (2021) Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. International Journal of Molecular Sciences 22:24, pages 13302.
Crossref
Crossref
Qiang Zhang, Canhua Hao, Yuhang Miao, Yinling Yun, Xiaoya Sun, Yinbo Pan, Jie Sun & Xiaojing Wang. (2021) Design and synthesis of benzyl aminocoumarin and its anti-Alzheimer's activity. New Journal of Chemistry 45:37, pages 17287-17300.
Crossref
Crossref
Elisa Uliassi, Andressa Souza de Oliveira, Luciana de Camargo Nascente, Luiz Antonio Soares Romeiro & Maria Laura Bolognesi. (2021) Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer’s Disease. Molecules 26:18, pages 5441.
Crossref
Crossref
Ramón Cacabelos, Juan Carril, Lola Corzo, Lucía Fernández-Novoa, Rocío Pego, Natalia Cacabelos, Pablo Cacabelos, Margarita Alcaraz, Iván Tellado & Vinogran Naidoo. (2021) Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease. Pharmaceuticals 14:4, pages 366.
Crossref
Crossref
Parteek Prasher & Mousmee Sharma. (2021) Medicinal Chemistry of Indane and Its Analogues: A Mini Review. ChemistrySelect 6:11, pages 2658-2677.
Crossref
Crossref
Miroslav Pohanka & Jitka Zakova. (2021) A Smartphone Camera Colorimetric Assay of Acetylcholinesterase and Butyrylcholinesterase Activity. Sensors 21:5, pages 1796.
Crossref
Crossref
Shvetank Bhatt, Lakshman Puli & Chandragauda R. Patil. (2021) Role of reactive oxygen species in the progression of Alzheimer’s disease. Drug Discovery Today 26:3, pages 794-803.
Crossref
Crossref
Maria D. Auxtero, Susana Chalante, Mário R. Abade, Rui Jorge & Ana I. Fernandes. (2021) Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction. Pharmaceutics 13:1, pages 124.
Crossref
Crossref